By Richard Macrae Gordon - Founder

COVID-19: Why the Omicron Variant Might Be The Best Pandemic News Yet

December 1, 2021

World markets have been rattled by the emergence of the latest variant of SARS-CoV-2 – and with good reason.

It has so many more mutations than previous variants that current vaccines and prior infections will likely provide little protection. Moderna’s CEO, Stéphane Bancel, recently stated "There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta".


From admittedly limited data, the propensity with which infection can be passed from one person to another seems to be much higher with Omicron, than with Delta. It has quickly displaced Delta to be responsible for the majority of new infections in a number of places in Africa – and is now present in a growing number of countries around the world.

The likelihood that Omicron will become the dominant global variant seems very high at this stage.

The Hope of Low Severity

The severity of infections caused by Omicron seem relatively mild at this stage, with a somewhat different palette of symptoms to prior variants. There appears to be no loss of taste, or smell. Instead, extreme fatigue, headaches and a dry cough seem to be the defining characteristics. According to Angelique Coetzee, chairperson of the South African Medical Association, the symptoms associated with Omicron are “extremely mild” so far (watch the video here).

Make no mistake, if this holds true as larger numbers of people are infected around the world, this is very good news indeed.

It would mean that we have a variant which outcompetes all the deadlier variants of the virus – and causes only mild symptoms.

Not long to Wait…

One way or another, we’ll find out very quickly which way this will go. Omicron is spreading around the world like wildfire and case numbers will quickly grow. We'll start getting much more substantial data within a couple of weeks.

The nightmare option is still a possibility (if Omicron turns out to be very dangerous indeed), but at this stage, there remains some cause for hope...

IMPORTANT INFORMATION:Afinitiv LLC is a United States Securities and Exchange Commission Registered Investment Advisor (RIA), formed under the laws of the State of Nevada USA, and duly registered under Section 203(c)(2)(A) of the Investment Advisor Act of 1940 (CRD: 305672). The following does not constitute a solicitation to invest in securities. All investments represent a risk of capital losses and all investors should consider whether an investment is appropriate for them, with regard to their objectives, required form and level of returns, tolerance for potential capital losses, liquidity and investment time frames, regardless of any advice they may have received. Afinitiv LLC does not guarantee investment returns, or the security of invested capital. Some investments may have less liquidity than others, which means that, under certain circumstances, an investor may not be able to redeem their investment for an extended period of time. Please click to view our Form ADV Part 2A and Privacy Policy. For more information, please contact: Please note that there may be tax implications and fees associated with transferring an investment balance from any account, to any other account and you should consult a tax professional if you are unsure of what this may mean for you. Any investment decisions made by us on your behalf are not based on a detailed understanding of your personal circumstances and accordingly may not be appropriate for you. Please consider this prior to opening an account with us. *Percentage fees charged by us are calculated on the basis of the amount of money invested with us. Investments in securities are not FDIC insured, not bank guaranteed and may lose value. *We do not charge additional fees of any sort, although additional costs (such as brokerage costs) may be incurred when investments are either bought, or sold (we do not benefit from any such fees). While we employ algorithmic, machine learning, artificial intelligence and other assistive technologies in our portfolio construction process, final investment decisions are made by human professionals...for now.
Customer Relationship Summary

(c) Copyright Afinitiv LLC 2023